Jody Voorspoels,,Ph.D serves as the Chairman of Scientific advisory board and Chief Scientific Officer of SEPS Pharma NV. Dr. Voorspoels's Ph.D. work focused on the use of bioadhesive drug delivery systems for both systemic and local applications. In 2000, he joined Tibotec, where he was responsible for early formulation of a number of new HIV compounds. In 2002, he joined Johnson & Johnson PRD (Janssen Pharmaceutica). As principal scientist, he was responsible for the development of solid dosage forms. In this function he obtained two Johnson & Johnson awards, The Philip B. Hofmann Research Scientist Award and the Johnson Medal, the most prestigion award within Johnson & Johnson for his work on the formulation and spray drying technology for Intelence™, a novel NNRTI HIV drug. He has a broad experience in the formulation and process development of HIV, CNS, metabolic and oncology drugs. He has developed drug delivery systems from immediate release to controlled release, for water soluble to poorly soluble drugs, liquid to solid dosage forms. Dr. Voorspoels was leading an innovation team within drug product development and was a member of the innovation taskforce of Janssen Pharmaceutica. Dr. Voorspoels is a pharmacist graduated from Ghent University and holds a Ph.D. in pharmaceutical technology from Ghent University.

  bioadhesive drug delivery systems